02/02/2012

Gilead Sciences announces fourth quarter and full year 2011 financial results

Fourth guarter product sales of $2.13 billion, up 11% year over year; Full year 2011 product sales of $8.10 billion, up 10% over 2010; Full year 2011 non-GAAP EPS of $3.86, up 5% over 2010; Full year 2011 operating cash flows of $3.64 billion.

Read the press release here.

Gilead Sciences, Inc.

http://www.gilead.com/

Share this page
Email this page to a friend Share this page on Digg Share this page on StumbleUpon Share this page on del.icio.us Share this page on Reddit Share this page on Facebook More...

DISCLAIMER

The EATG is not responsible for the content of this article. It does not necessarily reflect EATG views or opinions.

FAIR USE NOTICE

The information above may contain copyrighted material which has not always been specifically authorised by the copyright owner. Such material is made available for educational purposes to advance the understanding of scientific, ethical, legal and social issues. It is believed that this constitutes a 'fair use' of any such copyrighted material. This material is distributed without profit via the subscription to the daily digest.
European AIDS Treatmen.../Global HIV News/Pharma Industry/
Print